
{{Infobox United States federal proposed legislation
| name =
| fullname        = To prioritize funding for the National Institutes of Health to discover treatments and cures, to maintain global leadership in medical innovation, and to restore the purchasing power the NIH had after the historic doubling campaign that ended in fiscal year 2003.
| acronym         =
| nickname        =
| introduced in the = 113th
| introduceddate   =
| sponsored by    = [[Rosa DeLauro|Rep. Rosa L. DeLauro (D, CT-3)]]
| number of co-sponsors = 1
| public law url  =
| cite public law =
| cite statutes at large =
| acts affected =
| acts repealed   =
| title affected   =
| sections created =
| sections affected = {{USC|2|901}}
| agenciesaffected = [[National Institutes of Health]], [[Centers for Disease Control and Prevention]], [[Food and Drug Administration]]
| authorizationsofappropriations =
| appropriations =
| leghisturl      =
| introducedin    = House
| introducedbill  = {{USBill|113|hr|5580}}
| introducedby    = [[Rosa DeLauro|Rep. Rosa L. DeLauro (D, CT-3)]]
| introduceddate  = September 18, 2014
| committees      = [[United States House Committee on the Budget]]
| passedbody1     =
| passeddate1     =
| passedvote1     =
| passedbody2     =
| passedas2       =
| passeddate2     =
| passedvote2     =
| conferencedate  =
| passedbody3     =
| passeddate3     =
| passedvote3     =
| agreedbody3     =
| agreeddate3     =
| agreedvote3     =
| agreedbody4     =
| agreeddate4     =
| agreedvote4     =
| passedbody4     =
| passeddate4     =
| passedvote4     =
| signedpresident =
| signeddate      =
| unsignedpresident =
| unsigneddate    =
| vetoedpresident =
| vetoeddate      =
| overriddenbody1 =
| overriddendate1 =
| overriddenvote1 =
| overriddenbody2 =
| overriddendate2 =
| overriddenvote2 =
| amendments      =
| SCOTUS cases    =
}}
++++++++++++++++++++++++++++++




Acts impacted, by reference count:


Sections impacted, by reference count:
	1:	{{USC|2|901}}

-30-